Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MORPHINE vs MOSUNETUZUMAB-AXGB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MORPHINE vs MOSUNETUZUMAB-AXGB: Safety Overview

Metric MORPHINE MOSUNETUZUMAB-AXGB
Total FAERS Reports 120,595 198
Deaths Reported 38,212 13
Death Rate 31.7% 6.6%
Hospitalizations 17,386 48
Average Patient Age 53.1 yrs 63.5 yrs
% Female Patients 51.1% 56.1%
FDA Approval Date Apr 12, 2016 N/A
Manufacturer Hospira, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription